23 research outputs found

    Perancangan Tabung Vaksin Hewan Berbahan Dasar Polivinil Klorida (PVC) Dengan Mengunakan Elemen Peltier

    Full text link
    The vaccine is one of the ways to prevent disease in livestock as an antibody. These vaccines are very vulnerable because it should not be exposed to direct sunlight and should not be frozen. For some types of vaccines should be stored at a temperature 2oC - 8oC. The toughest obstacle when should bring the vaccine to remote areas that are difficult to reach and have no major infrastructure such as adequate road. The cooling tubes planning has the dimensions of the tubes used are 3 inches and 4 inches. High tube 3 inches is 14.6 cm in size and high 4 inches is 19.8 cm made polyvinyl chloride. The planning results retrieved the tensile that occurs in the cooling tube sheath 38,144 kg/〖cm〗^2. Tensile on sheath insulating space 68,766 kg/〖cm〗^2. The shear stress of cooling space cover 0,00093 kg/〖cm〗^2. Shear stress on the cover tube 9,479 kg/〖cm〗^2. Press the voltage going to the metal welding 8,656 kg/〖cm〗^2. Voltage drop bolt permits 74 N/mm2. The shear stress permits 44,4 N/mm2. The diameter bolt required 0,278 m

    Betel nut chewing, oral premalignant lesions, and the oral microbiome - Fig 4

    No full text
    <p><b>a.</b> Relative abundance of oral bacteria taxa: current betel nut chewers vs. former/never chewers (FDR-corrected p<0.05). <b>b.</b> Relative abundance of oral bacteria taxa: long-term betel nut chewers (≥10 yrs.) vs. never chewers (FDR-corrected p<0.05). <b>c.</b> Relative abundance of oral bacteria taxa: betel nut chewers with oral lesions vs. chewers/non-chewers without oral lesions (FDR-corrected p<0.05).</p

    Comparison of Oral Bacteria Within-Sample (Alpha) Diversity by Betel Nut Chewing History<sup>a</sup>.

    No full text
    <p>Comparison of Oral Bacteria Within-Sample (Alpha) Diversity by Betel Nut Chewing History<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0172196#t002fn001" target="_blank"><sup>a</sup></a>.</p

    Description of statin use after cancer diagnosis by name, lipophilicity, potencity, intensity, duration, consistency of use (n = 2456).

    No full text
    <p>* Categories are not mutually exclusive for these variables</p><p>Description of statin use after cancer diagnosis by name, lipophilicity, potencity, intensity, duration, consistency of use (n = 2456).</p

    Relative hazard of death for statin use after cancer diagnosis vs. no statin use (n = 7813).

    No full text
    <p>HR = hazard ratio for statin use; IGT = impaired glucose tolerance, COPD = chronic obstructive pulmonary disease</p><p>Relative hazard of death for statin use after cancer diagnosis vs. no statin use (n = 7813).</p

    Multivariable-adjusted association between statin use after diagnosis with pancreatic cancer and overall survival in <i>substrata of covariates</i>.

    No full text
    <p>Note: Stratified analysis in which statistically significant associations of statin use after cancer diagnosis with survival are highlighted in <b>bold</b> type</p><p>Multivariable-adjusted association between statin use after diagnosis with pancreatic cancer and overall survival in <i>substrata of covariates</i>.</p
    corecore